Organon & Co. (OGN) revenue & profit
Organon & Co. (OGN): revenue $6.2B, net income $187M in 2025; latest quarter -2.3% year over year. From SEC filings.
$6.2BRevenue 2025
TickerOGN (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$6.2B
Net income 2025$187M
Net margin3%
Annual revenue growth-2.9%
Latest quarter (2026 Q2) · Revenue$1.6B
vs. same quarter last year-2.3%
Latest quarter · Net income$108M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $6.2B | $917M | |
| 2023 | $6.3B | $1B | |
| 2024 | $6.4B | $864M | |
| 2025 | $6.2B | $187M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.